All Updates

All Updates

icon
Filter
Funding
Tierra Biosciences raises USD 11.4 million in Series A funding to strengthen AI capabilities
AI Drug Discovery
Mar 12, 2024
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
AI Drug Discovery

AI Drug Discovery

Mar 12, 2024

Tierra Biosciences raises USD 11.4 million in Series A funding to strengthen AI capabilities

Funding

  • AI-driven protein synthesis platform Tierra Biosciences has raised USD 11.4 million in a Series A funding round led by Material Impact with contributions from Prosus Ventures, In-Q-Tel (IQT), Hillspire, and others.

  • The funds will be used to reach a broader customer base and partner network, strengthen its AI data generation capabilities, and assemble a commercial team to grow sales.

  • Tierra Biosciences, formerly known as Synvitrobio, is a synthetic biology company that focuses on discovering and developing bio-based materials through its proprietary cell-free synthetic biology technology. The company's Tierra Protein Platform leverages automation and AI to facilitate the synthesis of custom proteins outside of living cells. The company has produced over 5,000 proteins to date offering a way to speed up the protein development process from months to weeks.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.